Sunitinib rechallenge in advanced renal cell carcinoma: outcomes of a multicenter retrospective study
Sign Up to like & getrecommendations! Published in 2019 at "Cancer Chemotherapy and Pharmacology"
DOI: 10.1007/s00280-019-03913-3
Abstract: The aim of this multicenter study was to evaluate the clinical outcomes of patients with metastatic renal cell carcinoma (mRCC) who received sunitinib retreatment. Clinical data from patients treated with sunitinib rechallenge in nine Spanish… read more here.
Keywords: renal cell; cell carcinoma; sunitinib rechallenge; study ... See more keywords